Prot #68284528MMY2003: A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma (CARTITUDE-2)

Project: Research project

Project Details

StatusActive
Effective start/end date2/11/20 → 2/11/26

Funding

  • Janssen Research & Development, LLC ((OE) Prot #68284528MMY2003)